Differential expression in all HSPCs comparing MDS versus Control followed by GSEA revealed a significant enrichment for pro-inflammatory pathways, such as TNFα via NF-κB in MDS (Supplementary Fig. 8A, B). The gene discussed is NFKB1; the disease is myelodysplastic syndrome.